The Outsourced Clinical Trials & Formulation Market to get digitally distilled fPosted by Steve Sharma on May 9th, 2022 The Outsourced Clinical Trials & Formulation Market is destined to grow on an impertinent note, i.e. reaching US$ 19.6 Bn at a CAGR of 6.7% between 2022-2027. Personalization has taken over almost every sphere of the industry verticals, and healthcare is no exception. People have started looking at their healthcare picture such that they could actively take part in improving their physical and mental health on the daily basis. This personalization will be the face of the healthcare vertical in the forecast period. Formulation development, being a crucial part of product/drug development, has highly impacted pharmaceutical products’ patentability, sustainability, and success. The global outsourced clinical trials & formulation market recorded sales worth US$ 13.3 Bn in 2021, and is estimated to expand at a CAGR of 6.7% over the forecast period (2022-2032). Like it? Share it! More by this author |